Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-19-059094
Filing Date
2019-11-04
Accepted
2019-11-01 19:35:10
Documents
1
Period of Report
2019-12-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tv531449-pre14a.htm PRE 14A 376747
  Complete submission text file 0001104659-19-059094.txt   377805
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-13341 | Film No.: 191188054
SIC: 2836 Biological Products, (No Diagnostic Substances)